EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Genetic characterization of KCNQ1 variants improves risk stratification in type 1 long QT syndrome patients

Charles Morgat iD, Véronique Fressart iD, Alessandra Pia Porretta iD, Nathalie Neyroud, Anne Messali, Yassine Temmar, Vincent Algalarrondo iD, Elodie Surget iD, Adrien Bloch, Antoine Leenhardt iD, Isabelle Denjoy iD, Fabrice Extramiana iD

Europace · 2024

DOI: 10.1093/europace/euae136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2024. Verfasst von Charles Morgat und 11 weiteren Autor:innen. Beteiligte Einrichtung: CNMR Maladies Cardiaques Héréditaires Rares, APHP, Hôpital Bichat, 46 rue Henri Huchard, 75018 Paris, France. Hauptthemen laut MEDLINE: KCNQ1 Potassium Channel, Romano-Ward Syndrome. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

KCNQ1 mutations cause QTc prolongation increasing life-threatening arrhythmias risks. Heterozygous mutations [type 1 long QT syndrome (LQT1)] are common. Homozygous KCNQ1 mutations cause type 1 Jervell and Lange–Nielsen syndrome (JLNS) with deafness and higher sudden cardiac death risk. KCNQ1 variants causing JLNS or LQT1 might have distinct phenotypic expressions in heterozygous patients. The aim of this study is to evaluate QTc duration and incidence of long QT syndrome–related cardiac events according to genetic presentation. Methods and results We enrolled LQT1 or JLNS patients with class IV/V KCNQ1 variants from our inherited arrhythmia clinic (September 1993 to January 2023). Medical history, ECG, and follow-up were collected. Additionally, we conducted a thorough literature review for JLNS variants. Survival curves were compared between groups, and multivariate Cox regression models identified genetic and clinical risk factors. Among the 789 KCNQ1 variant carriers, 3 groups were identified: 30 JLNS, 161 heterozygous carriers of JLNS variants (HTZ-JLNS), and 550 LQT1 heterozygous carriers of non-JLNS variants (HTZ-Non-JLNS). At diagnosis, mean age was 3.4 ± 4.7 years for JLNS, 26.7 ± 21 years for HTZ-JLNS, and 26 ± 21 years for HTZ-non-JLNS; 55.3% were female; and the mean QTc was 551 ± 54 ms for JLNS, 441 ± 32 ms for HTZ-JLNS, and 467 ± 36 ms for HTZ-Non-JLNS. Patients with heterozygous JLNS mutations (HTZ-JLNS) represented 22% of heterozygous KCNQ1 variant carriers and had a lower risk of cardiac events than heterozygous non-JLNS variant carriers (HTZ-Non-JLNS) [hazard ratio (HR) = 0.34 (0.22–0.54); P < 0.01]. After multivariate analysis, four genetic parameters were independently associated with events: haploinsufficiency [HR = 0.60 (0.37–0.97); P = 0.04], pore localization [HR = 1.61 (1.14–1.2.26); P < 0.01], C-terminal localization [HR = 0.67 (0.46–0.98); P = 0.04], and group [HR = 0.43 (0.27–0.69); P < 0.01].

Conclusion

Heterozygous carriers of JLNS variants have a lower risk of cardiac arrhythmic events than other LQT1 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KCNQ1 Potassium ChannelRomano-Ward SyndromeHumansFemaleMaleRisk AssessmentRisk FactorsChildElectrocardiographyChild, PreschoolHeterozygoteMutationJervell-Lange Nielsen SyndromeGenetic Predisposition to DiseaseInfantAdultAdolescentPhenotypeRetrospective StudiesDeath, Sudden, CardiacYoung AdultIncidence

Stichwörter der Autor:innen

KCNQ1Heterozygous carriersJervell and Lange–Nielsen syndromeRisk stratificationType 1 long QT syndrome

Substanzen

KCNQ1 Potassium ChannelKCNQ1 protein, human

Autor:innen und Institutionen

  • CNMR Maladies Cardiaques Héréditaires Rares, APHP, Hôpital Bichat, 46 rue Henri Huchard, 75018 Paris, France.
  • AP-HP, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
  • Service of Cardiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Sorbonne Université, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, Paris, France.
  • AP-HP, Unité Rythmologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.

ORCID-Profile: Charles Morgat, Véronique Fressart, Alessandra Pia Porretta, Vincent Algalarrondo, Elodie Surget, Antoine Leenhardt, Isabelle Denjoy, Fabrice Extramiana

Zitieren

APA

Morgat, C., Fressart, V., Porretta, A. P., Neyroud, N., Messali, A., Temmar, Y., Algalarrondo, V., Surget, E., Bloch, A., Leenhardt, A., Denjoy, I., & Extramiana, F. (2024). Genetic characterization of KCNQ1 variants improves risk stratification in type 1 long QT syndrome patients. Europace. https://doi.org/10.1093/europace/euae136

Vancouver

Morgat C, Fressart V, Porretta AP, Neyroud N, Messali A, Temmar Y, et al. Genetic characterization of KCNQ1 variants improves risk stratification in type 1 long QT syndrome patients. Europace. 2024. doi:10.1093/europace/euae136

BibTeX
@article{Morgat2024,
  author = {Morgat, Charles and Fressart, Véronique and Porretta, Alessandra Pia and Neyroud, Nathalie and Messali, Anne and Temmar, Yassine and Algalarrondo, Vincent and Surget, Elodie and Bloch, Adrien and Leenhardt, Antoine and Denjoy, Isabelle and Extramiana, Fabrice},
  title = {Genetic characterization of KCNQ1 variants improves risk stratification in type 1 long QT syndrome patients},
  journal = {Europace},
  year = {2024},
  doi = {10.1093/europace/euae136}
}
Kostenlos starten →